CN101474236A - Ganoderma lucidum wall-broken spore powder capsule - Google Patents
Ganoderma lucidum wall-broken spore powder capsule Download PDFInfo
- Publication number
- CN101474236A CN101474236A CNA200810001303XA CN200810001303A CN101474236A CN 101474236 A CN101474236 A CN 101474236A CN A200810001303X A CNA200810001303X A CN A200810001303XA CN 200810001303 A CN200810001303 A CN 200810001303A CN 101474236 A CN101474236 A CN 101474236A
- Authority
- CN
- China
- Prior art keywords
- spore powder
- ganoderma lucidum
- broken
- sporoderm
- ganoderan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 37
- 239000002775 capsule Substances 0.000 title claims abstract description 21
- 240000008397 Ganoderma lucidum Species 0.000 title claims description 36
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims description 36
- 239000000284 extract Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims description 16
- 241000222336 Ganoderma Species 0.000 abstract description 8
- 230000036737 immune function Effects 0.000 abstract description 6
- 150000004676 glycans Chemical class 0.000 abstract description 5
- 229920001282 polysaccharide Polymers 0.000 abstract description 4
- 239000005017 polysaccharide Substances 0.000 abstract description 4
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical group O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 3
- 229940074393 chlorogenic acid Drugs 0.000 description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 3
- 235000001368 chlorogenic acid Nutrition 0.000 description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003471 anti-radiation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- -1 triterpenoid compound Chemical class 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical group [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical group [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011777 magnesium Chemical group 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000011669 selenium Chemical group 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Chemical group 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a glossy ganoderma wall-broken spore powder capsule, relating to medical-edible health products. The capsule is made from 50 to 90 percent of glossy ganoderma wall-broken spore powder, 8 to 34 percent of glossy ganoderma polysaccharide and 2 to 16 percent of honeysuckle extracts. The capsule has the health functions of improving the body immune function, inhibiting tumor and delaying senility, and raw materials are available.
Description
Technical field
The present invention relates to the medicine-food two-purpose health product technology field, especially relate to a kind of capsules of wall broken spore powder of ganoderma lucidum with physical strength reinforcing and adjusting immunologic function.
Background technology
Along with progress of science and technology and economic development, people's rhythm of life is accelerated day by day, grows with each passing day from the pressure of each side such as work, life and society, causes majority very easily tired, immunologic hypofunction.At present, more existing resisting fatigue, antidotal food or medicine exist deficiencies such as function singleness in various degree.
Summary of the invention
The object of the present invention is to provide a kind of physical strength reinforcing and regulate the capsules of wall broken spore powder of ganoderma lucidum of immunologic function.
Technical solution of the present invention is:
A kind of capsules of wall broken spore powder of ganoderma lucidum is characterized in that: the raw material by following weight item is made:
Sporoderm-broken Ganoderma Lucidum Spore powder 50～90%
Ganoderan 8～34%
Flos Lonicerae extract 2～16%, above-mentioned raw materials weight sum is 100%.
Described capsules of wall broken spore powder of ganoderma lucidum is characterized in that: the raw material by following weight item is made:
Sporoderm-broken Ganoderma Lucidum Spore powder 70%
Ganoderan 20%
Flos Lonicerae extract 10%.
Described capsules of wall broken spore powder of ganoderma lucidum preparation method is: take by weighing Sporoderm-broken Ganoderma Lucidum Spore powder according to the above ratio, ganoderan, Flos Lonicerae extract makes component composition of the present invention through mixing and stirring, component composition is incapsulated make capsules of wall broken spore powder of ganoderma lucidum of the present invention.
Certainly, also can be processed into other dosage form with component composition by existing processing technology, as: tablet, soft capsule etc.
Described Sporoderm-broken Ganoderma Lucidum Spore powder is to adopt the low-temperature physics technology under vacuum state ganoderma lucidium spore powder wall breaking to be handled, and obtains the superfine powder of fineness more than 300 orders, sporoderm-broken rate 99%, polyoses content 2.96%.
Described ganoderan is Ganoderma extract, and specification is a ganoderan 10%～30%.
Described Flos Lonicerae extract mainly is chlorogenic acid Chlorogenic acid, and specification is 30% (HPLC).
The selected Sporoderm-broken Ganoderma Lucidum Spore powder of the present invention is Ganoderma elite place, and its main effective ingredient has: triterpenoid compound, ganoderan, organic germanium, purine class, protein, polypeptide, aminoacid, trace element and vitamin.Triterpenoid compound is one of main active of Sporoderm-broken Ganoderma Lucidum Spore powder, and its kind is a lot.Triterpene substance in the Ganoderma has the effect of cholesterol reducing, blood vessel dilating, can treat hypertension and hyperlipidemia.Simultaneously hepatosarcoma also there is obvious inhibitory action.In the triterpene substance of Sporoderm-broken Ganoderma Lucidum Spore powder; Ganodenic acid is a kind of important active component; it has intensive pharmacologically active; the effect of energy pain relieving, calmness, antiinflammatory, antiallergic, the liver protecting, inhibition tumor, ganoderan has the effect of regulating immunologic function, antitumor, blood sugar lowering, anti-radiation, antioxidation, promotion human inheritance factor nucleic acid (comprising DNA and RNA).Contain a large amount of organic germaniums in the Sporoderm-broken Ganoderma Lucidum Spore powder, it can bring out self interferon, increase NK cytoactive, activated macrophage, enhancing antibody generation and antitumor, defying age biological agent.The ability that it can strengthen the blood of human body oxygen uptake reaches more than 1.5 times, enhances metabolism, and eliminates interior free yl, prevents cell senescence; Can also press power taking from cancerous cell, its current potential is descended, anticancer worsens, and prevents to its place's diffusion.Purine substance in the Sporoderm-broken Ganoderma Lucidum Spore powder can reduce the stickiness of blood, anticoagulant, improve the oxygen delivery capacity of hemoglobin, the accelerate blood microcirculation, improve the oxygen delivery capacity of blood to the heart, brain organ, reduce the generation of cardiovascular and cerebrovascular disease, cerebral thrombosis, myocardial infarction are had good therapeutic effect.Sporoderm-broken Ganoderma Lucidum Spore powder also contains abundant microelements of calcium, ferrum, magnesium, zinc, selenium and vitamin B group in addition, plays a part useful to the health of human body.Human body, is higher than far away the absorbance of spore powder with crushed sporoderm 12% not more than 95% the effective ingredient absorbance of Sporoderm-broken Ganoderma Lucidum Spore powder.Experimental results show that Sporoderm-broken Ganoderma Lucidum Spore powder has anticancer, prevention and alleviates cardiovascular disease, alleviates nervous system disease, improves effects such as human immunologic function.
Ganoderan is one of Ganoderma Main Ingredients and Appearance, specification is a ganoderan 10%～30%, isolated ganoderan kind more than 200 at present from Ganoderma, its major part is a beta-glucan, and the quantity of hydroxyl replacement is relevant on its active strong and weak and the ramose degree of polysaccharide chain and side chain.The ganoderan activity research confirms, its energy human body immunity improving function, the phagocytic activity of enhancing macrophage, the ability of raising body hypoxia-bearing, strengthen the activity of superoxide dismutase (SOD), suppress the generation of oxygen-derived free radicals and the peroxidization of erythrocyte lipid.Improve the ability of anti-radiation and inhibition tumor, improve liver, bone marrow, the synthetic DNA (deoxyribonucleic acid) (DNA) of blood, ribonucleic acid (RNA), proteinic ability.Illustrate that ganoderan can keep the body stable state, reaches strengthening the body resistance and function in delaying senility.The enhancing human body immunity function has remarkable, direct antitumor action, can suppress tumor growth and transfer.Unsaturated fatty acid: have vessel softening, purify the blood, eliminate the cell free radical.
Flos Lonicerae is JINHUA, Flos Lonicerae, Flos Lonicerae, Flos Lonicerae, Flos Lonicerae again.Be commonly called as the beggar.Be one of 70 kinds of definite rare medicinal herbss of State Council, belonging to one of the most frequently used medical material of tcm clinical practice, is the first-selected medical material of heat-clearing and toxic substances removing, and Flos Lonicerae extract mainly is rich in chlorogenic acid, have extensive antibacterial action, function of gallbladder promoting is arranged, stop blooding, increase leukocyte and antivirus action; Be used for the treatment of carbuncle furuncle, affection due to external wind and heat, pestilence from the beginning of, toxic-heat and blood stasis, determined curative effect.
The present invention combines Sporoderm-broken Ganoderma Lucidum Spore powder and ganoderan, is aided with the rare Chinese medicine Flos Lonicerae extract.Prescription is scientific and reasonable, has realized having complementary functions, and has given full play to synergistic function between the component, has the effect of tonifying both YIN and YANG, adjustment, enhancement body's immunity.
Capsules of wall broken spore powder of ganoderma lucidum of the present invention shows through effect experiment, toxicological experiment and stability experiment, remarkable, nontoxic, the good stability of its effect, and take proof through majority, have physical strength reinforcing and regulate the health product of immunologic function.
The specific embodiment
Embodiment 1: take by weighing Sporoderm-broken Ganoderma Lucidum Spore powder 70%, and ganoderan 20%, Flos Lonicerae extract 10% makes compositions of the present invention through abundant mixing and stirring, and said composition is incapsulated, bottles, and is packaged into box and promptly makes capsules of wall broken spore powder of ganoderma lucidum.Every net content of capsule is 0.25g, contains ganoderma lucidum crude polysaccharide g/100g 〉=4.6, instructions of taking: every day 3 times, each 3.
Embodiment 2: take by weighing Sporoderm-broken Ganoderma Lucidum Spore powder 80%, and ganoderan 15%, Flos Lonicerae extract 5% makes compositions of the present invention through abundant mixing and stirring, and said composition is incapsulated, bottles, and is packaged into box and promptly makes capsules of wall broken spore powder of ganoderma lucidum.Every net content of the every capsules of capsule is 0.25g, contains ganoderma lucidum crude polysaccharide g/100g 〉=4.6, instructions of taking: every day 3 times, each 3.
Embodiment 3: take by weighing Sporoderm-broken Ganoderma Lucidum Spore powder 70%, and ganoderan 20%, Flos Lonicerae extract 10% makes compositions of the present invention through abundant mixing and stirring, and said composition is incapsulated, bottles, and is packaged into box and promptly makes capsules of wall broken spore powder of ganoderma lucidum.Every net content of capsule is 0.25g, contains ganoderma lucidum crude polysaccharide g/100g 〉=4.6, instructions of taking: every day 3 times, each 3.
Claims (2)
1, a kind of capsules of wall broken spore powder of ganoderma lucidum is characterized in that: the raw material by following weight item is made:
Sporoderm-broken Ganoderma Lucidum Spore powder 50～90%
Ganoderan 8～34%
Flos Lonicerae extract 2～16%, above-mentioned raw materials weight sum is 100%.
2, capsules of wall broken spore powder of ganoderma lucidum according to claim 1 is characterized in that: the raw material by following weight item is made:
Sporoderm-broken Ganoderma Lucidum Spore powder 70%
Ganoderan 20%
Flos Lonicerae extract 10%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA200810001303XA CN101474236A (en) | 2008-01-01 | 2008-01-01 | Ganoderma lucidum wall-broken spore powder capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA200810001303XA CN101474236A (en) | 2008-01-01 | 2008-01-01 | Ganoderma lucidum wall-broken spore powder capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101474236A true CN101474236A (en) | 2009-07-08 |
Family
ID=40835077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA200810001303XA Pending CN101474236A (en) | 2008-01-01 | 2008-01-01 | Ganoderma lucidum wall-broken spore powder capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101474236A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103417584A (en) * | 2013-08-21 | 2013-12-04 | 四川九章生物化工科技发展有限公司 | Pharmaceutical composition and preparation method and application thereof |
| WO2015024218A1 (en) * | 2013-08-21 | 2015-02-26 | 四川九章生物科技有限公司 | Pharmaceutical composition, preparation method therefor and use thereof |
| CN105267287A (en) * | 2015-11-03 | 2016-01-27 | 安徽千方生物科技有限公司 | Anti-tumor traditional Chinese medicine preparation rich in sporoderm-broken ganoderma spore powder and method for preparing anti-tumor traditional Chinese medicine preparation |
| CN107308437A (en) * | 2017-06-26 | 2017-11-03 | 郑相国 | Treat and prevent solid beverage of esophagus cancer and preparation method thereof |
| CN107375896A (en) * | 2017-06-26 | 2017-11-24 | 郑相国 | For suppressing the Chinese patent drug of cancer cell multiplication |
| CN113368148A (en) * | 2021-06-30 | 2021-09-10 | 江苏菇神生物科技有限公司 | Ganoderma spore wall breaking method, wall-broken ganoderma spore powder prepared by same and device |
-
2008
- 2008-01-01 CN CNA200810001303XA patent/CN101474236A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103417584A (en) * | 2013-08-21 | 2013-12-04 | 四川九章生物化工科技发展有限公司 | Pharmaceutical composition and preparation method and application thereof |
| WO2015024218A1 (en) * | 2013-08-21 | 2015-02-26 | 四川九章生物科技有限公司 | Pharmaceutical composition, preparation method therefor and use thereof |
| US10238702B2 (en) | 2013-08-21 | 2019-03-26 | Sichuan Jiuzhang Biological Science And Technology Co., Ltd. | Pharmaceutical composition, preparation method therefor and use thereof |
| CN105267287A (en) * | 2015-11-03 | 2016-01-27 | 安徽千方生物科技有限公司 | Anti-tumor traditional Chinese medicine preparation rich in sporoderm-broken ganoderma spore powder and method for preparing anti-tumor traditional Chinese medicine preparation |
| CN107308437A (en) * | 2017-06-26 | 2017-11-03 | 郑相国 | Treat and prevent solid beverage of esophagus cancer and preparation method thereof |
| CN107375896A (en) * | 2017-06-26 | 2017-11-24 | 郑相国 | For suppressing the Chinese patent drug of cancer cell multiplication |
| CN113368148A (en) * | 2021-06-30 | 2021-09-10 | 江苏菇神生物科技有限公司 | Ganoderma spore wall breaking method, wall-broken ganoderma spore powder prepared by same and device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107771946A (en) | A kind of formula milk and its production method for contributing to middle-aged and old cardiovascular and cerebrovascular health | |
| CN101474236A (en) | Ganoderma lucidum wall-broken spore powder capsule | |
| CN102406115B (en) | Natural functional food for preventing cardiovascular and cerebrovascular diseases | |
| CN107616400A (en) | A kind of solid beverage of ganoderma lucidum small-molecular peptides compounding and preparation method thereof | |
| CN104001157A (en) | Compound preparation for preventing and treating osteoporosis and preparation method thereof | |
| KR101415697B1 (en) | A pharmaceutical composition comprising the combined extract of Crataegi Fructus and Citri Pericarpium for treating or preventing obesity or lipid-related metabolic disorder | |
| CN1994392B (en) | Compound drynaria capsule and tablet and preparation method thereof | |
| CN104382002A (en) | Maca tablet for alleviating fatigue | |
| CN104257793A (en) | Cholestin and preparation method of cholestin | |
| CN107495033A (en) | A kind of ferment drink that can alleviate gout and preparation method thereof | |
| CN103520302A (en) | Sea-buckthorn leaf anti-fatigue capsule and preparation method thereof | |
| CN101669640A (en) | Method for preparing health-care food by using ginkgo biloba extract (GBE) and bee pollen | |
| RU2408383C1 (en) | Composition with antineoplastic and adaptogenic activity (versions) and based drug (versions) | |
| CN104587424A (en) | Ginger-red date-fennel-clove bud-agilawood-containing traditional Chinese medicine composition and preparation method thereof | |
| CN103933146A (en) | Pollen product capable of adjusting human body immunity | |
| CN102524800A (en) | Composite cucumber seed powder and preparation method thereof | |
| CN113679051A (en) | Peony polypeptide powder, solid beverage and application thereof | |
| CN106723022A (en) | A kind of sika deer velvet antler peacilomyce hepiahi bacterium capsule and preparation method thereof | |
| CN1631217A (en) | Concentrated solution of acanthopanax root, royal jelly, pollen and honey and method for making it | |
| CN111280452A (en) | Novel natto polypeptide health food | |
| CN102948663A (en) | Rana japonica oil granules and preparation method thereof | |
| CN107970437A (en) | Cordyceps sinensis gram oncogene peptide | |
| CN1102396C (en) | Production process of compound meilingzhihua health food series | |
| CN1057683C (en) | Compound selenic-garlic health medicine and its preparation method | |
| KR20010035311A (en) | A COMPOSITION FOR AN ANTI-CANCER EFFECTS CONTAINING CHITOSAN, β- GLUCAN OF AGARCUS MUSH-ROOMS AND ORGANIC GERMANIUM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090708 |